|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lieberman DA: Clinical practice. Screening
for colorectal cancer. N Engl J Med. 361:1179–1187. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL,
Yu MH and Qin J: MicroRNA-187 inhibits tumor growth and invasion by
directly targeting CD276 in colorectal cancer. Oncotarget.
7:44266–44276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li N, Zhao X, Wang L, Zhang S, Cui M and
He J: miR-494 suppresses tumor growth of epithelial ovarian
carcinoma by targeting IGF1R. Tumour Biol. 37:7767–7776. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian J, Hu L, Li X, Geng J, Dai M and Bai
X: MicroRNA-130b promotes lung cancer progression via PPAR
γ/VEGF-A/BCL-2-mediated suppression of apoptosis. J Exp Clin Cancer
Res. 35:1052016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Z, Qin L and Li S: miR-411
contributes the cell proliferation of lung cancer by targeting
FOXO1. Tumour Biol. 37:5551–5560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Xu G, Liu G, Ye Y, Zhang C, Fan
C, Wang H, Cai H, Xiao R, Huang Z and Luo Q: miR-411-5p inhibits
proliferation and metastasis of breast cancer cell via targeting
GRB2. Biochem Biophys Res Commun. 476:607–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia K, Zhang Y, Cao S, Wu Y, Guo W, Yuan W
and Zhang S: miR-411 regulated ITCH expression and promoted cell
proliferation in human hepatocellular carcinoma cells. Biomed
Pharmacother. 70:158–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang M, Wen TF, He LH, Li C, Zhu WJ and
Trishul NM: A six-microRNA set as prognostic indicators for bile
duct cancer. Int J Clin Exp Med. 8:17261–17270. 2015.PubMed/NCBI
|
|
13
|
Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao
YP, Li HC and Wu XN: Screening of microRNA in patients with
esophageal cancer at same tumor node metastasis stage with
different prognoses. Asian Pac J Cancer Prev. 14:139–143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan
S, Cai H, Luo Q, Lv Z and Fan L: miR-194 inhibits the
proliferation, invasion, migration, and enhances the
chemosensitivity of non-small cell lung cancer cells by targeting
forkhead box A1 protein. Oncotarget. 7:13139–13152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue L, Xu Z, Wang K, Wang N, Zhang X and
Wang S: Network analysis of microRNAs, transcription factors,
target genes and host genes in human anaplastic astrocytoma. Exp
Ther Med. 12:437–444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang L, Yang C, Song Y, Liu W, Wang K, Li
S and Zhang Y: MicroRNA-23a-3p promotes the development of
osteoarthritis by directly targeting SMAD3 in chondrocytes. Biochem
Biophys Res Commun. 478:467–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang PY, Chen CC, Chang YS, Tsai WS, You
JF, Lin GP, Chen TW, Chen JS and Chan EC: MicroRNA-223 and
microRNA-92a in stool and plasma samples act as complementary
biomarkers to increase colorectal cancer detection. Oncotarget.
7:10663–10675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng B, Wang B, Fang J, Zhu X, Cao Z, Lin
Q, Zhou L and Sun X: MiRNA-203 suppresses cell proliferation,
migration and invasion in colorectal cancer via targeting of
EIF5A2. Sci Rep. 6:283012016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang F, Xie YQ, Tang SQ, Wu XB and Zhu HY:
miR-143 regulates proliferation and apoptosis of colorectal cancer
cells and exhibits altered expression in colorectal cancer tissue.
Int J Clin Exp Med. 8:15308–15312. 2015.PubMed/NCBI
|
|
21
|
Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi
L, Liu X, Bai J, Deng M, Shuai X, et al: miR-219-5p plays a tumor
suppressive role in colon cancer by targeting oncogene Sall4. Oncol
Rep. 34:1923–1932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Cao F, Li X, Miao H, E J, Xing J
and Fu CG: miR-320b suppresses cell proliferation by targeting
c-Myc in human colorectal cancer cells. BMC Cancer. 15:7482015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai C, Ashktorab H, Pang X, Zhao Y, Sha W,
Liu Y and Gu X: MicroRNA-211 expression promotes colorectal cancer
cell growth in vitro and in vivo by targeting tumor suppressor
CHD5. PLoS One. 7:e297502012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Fei B, Wang Q, Song M, Yin Y,
Zhang B, Ni S, Guo W, Bian Z, Quan C, et al: MicroRNA-638 inhibits
cell proliferation, invasion and regulates cell cycle by targeting
tetraspanin 1 in human colorectal carcinoma. Oncotarget.
5:12083–12096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang WL, Cao J, Xu B, Yang P, Shen F, Sun
Z, Li WL, Wang Q and Liu F: miR-892a regulated PPP2R2A expression
and promoted cell proliferation of human colorectal cancer cells.
Biomed Pharmacother. 72:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ooms LM, Horan KA, Rahman P, Seaton G,
Gurung R, Kethesparan DS and Mitchell CA: The role of the inositol
polyphosphate 5-phosphatases in cellular function and human
disease. Biochem J. 419:29–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bielas SL, Silhavy JL, Brancati F,
Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS,
Abdel-Aleem A, Rosti RO, et al: Mutations in INPP5E, encoding
inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol
signaling to the ciliopathies. Nat Genet. 41:1032–1036. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hakim S, Bertucci MC, Conduit SE, Vuong DL
and Mitchell CA: Inositol polyphosphate phosphatases in human
disease. Curr Top Microbiol Immunol. 362:247–314. 2012.PubMed/NCBI
|
|
29
|
Hakim S, Dyson JM, Feeney SJ, Davies EM,
Sriratana A, Koenig MN, Plotnikova OV, Smyth IM, Ricardo SD, Hobbs
RM and Mitchell CA: Inpp5e suppresses polycystic kidney disease via
inhibition of PI3K/Akt-dependent mTORC1 signaling. Hum Mol Genet.
25:2295–2313. 2016. View Article : Google Scholar : PubMed/NCBI
|
